查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物分析测试服务市场报告：2030 年趋势、预测与竞争分析
市场调查报告书
商品编码
1416288

生物分析测试服务市场报告：2030 年趋势、预测与竞争分析

Bioanalytical Testing Services Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

生物分析测试服务的趋势和预测

预计到 2030 年，全球生物分析测试服务市场将达到约 94 亿美元，2024 年至 2030 年的复合年增长率为 15.2%。该市场的主要驱动力是越来越重视开发先进的生物分析技术以加强测试以及外包临床实验室服务的成长趋势。全球生物分析测试服务市场的未来前景广阔，肿瘤学、感染疾病、传染病、胃肠病学和心臟病学市场充满机会。

生物分析测试服务市场洞察

Lucintel 预测，由于慢性病的流行和临床试验数量的增加，基于细胞的检测将在整个预测期内仍然是最大的部分。

由于针对癌症的临床试验数量不断增加，肿瘤学将继续成为该市场的最大细分市场。

由于专注于开发治疗各种疾病的新药，预计亚太地区将在预测期内实现最高成长。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球生物分析测试服务市场预计将达到 94 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球生物分析测试服务市场预计将以15.2%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动力是越来越重视开发先进的生物分析技术以加强测试以及外包临床实验室服务的成长趋势。

Q4.市场的主要细分市场是：

A4. 生物分析测试服务市场的未来前景广阔，肿瘤学、神经学、感染疾病、胃肠病学和心臟病学市场充满机会。

Q5.市场的主要企业是：

A5. 一些主要的生物分析测试服务公司是：

  • Charles River
  • Medpace
  • WuXi AppTec
  • Eurofins Scientific
  • IQVIA
  • SGS SA
  • Laboratory Corporation
  • Intertek
  • Syneos Health
  • ICON

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计，由于慢性病的流行和临床试验数量的增加，在整个预测期内基于细胞的检测仍将是最大的部分。

Q7. 未来五年预计哪些地区的市场成长最大？

A7.由于专注于开发治疗各种疾病的新药，预计亚太地区在预测期内将出现最高增长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球生物分析测试服务市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球生物分析测试服务市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球生物分析测试服务市场
    • 基于细胞的检测
    • 基于细菌细胞的测定
    • 基于病毒细胞的检测
    • 病毒测试
    • 体外病毒检测
    • 体内病毒检测
    • 物种特异性病毒PCR检测
    • 方法开发、最佳化和检验
    • 其他的
  • 全球生物分析测试服务市场（按应用）
    • 瘤
    • 神经病学
    • 感染疾病
    • 消化内科
    • 心臟病
  • 按最终用途分類的全球生物分析测试服务市场
    • 製药和生物製药公司
    • 合约开发/製造组织
    • 合约研究组织

第四章 2018-2030年区域市场趋势及预测分析

  • 全球生物分析测试服务市场（按地区）
  • 北美生物分析测试服务市场
  • 欧洲生物分析测试服务市场
  • 亚太生物分析测试服务市场
  • 其他地区生物分析检测服务市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球生物分析测试服务市场成长机会
    • 全球生物分析测试服务市场成长机会（按应用）
    • 全球生物分析测试服务市场成长机会（依最终用途）
    • 按地区分類的全球生物分析测试服务市场成长机会
  • 全球生物分析测试服务市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球生物分析测试服务市场的产能扩张
    • 全球生物分析测试服务市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Charles River
  • Medpace
  • WuXi AppTec
  • Eurofins Scientific
  • IQVIA
  • SGS SA
  • Laboratory Corporation
  • Intertek
  • Syneos Health
  • ICON
简介目录

Bioanalytical Testing Services Trends and Forecast

The future of the global bioanalytical testing services market looks promising with opportunities in the oncology, neurology, infectious diseases, gastroenterology, and cardiology markets. The global bioanalytical testing services market is expected to reach an estimated $9.4 billion by 2030 with a CAGR of 15.2% from 2024 to 2030. The major drivers for this market are increasing emphasis towards the development of advanced bioanalytical technologies for enhanced testing and growing trend of outsourcing laboratory testing services.

A more than 150-page report is developed to help in your business decisions.

Bioanalytical Testing Services by Segment

The study includes a forecast for the global bioanalytical testing services by type, application, end use, and region.

Bioanalytical Testing Services Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Cell-Based Assays
  • Bacterial Cell-Based Assays
  • Viral Cell-Based Assays
  • Virology Testing
  • In Vitro Virology Testing
  • In Vivo Virology Testing
  • Species-Specific Viral PCR Assays
  • Method Development, Optimization, And Validation
  • Others

Bioanalytical Testing Services Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Oncology
  • Neurology
  • Infectious Diseases
  • Gastroenterology
  • Cardiology

Bioanalytical Testing Services Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical And Biopharmaceutical Companies
  • Contract Development And Manufacturing Organizations
  • Contract Research Organizations

Bioanalytical Testing Services Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bioanalytical Testing Services Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bioanalytical testing services companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bioanalytical testing services companies profiled in this report include-

  • Charles River
  • Medpace
  • WuXi AppTec
  • Eurofins Scientific
  • IQVIA
  • SGS SA
  • Laboratory Corporation
  • Intertek
  • Syneos Health
  • ICON

Bioanalytical Testing Services Market Insights

Lucintel forecasts that cell-based assays will remain the largest segment over the forecast period due to high occurence of chronic diseases and the increasing number of clinical trials.

Within this market, oncology will remain the largest segment due to growing number of clinical trials conducted for cancer.

APAC is expected to witness highest growth over the forecast period due to growing emphasis on developing new drugs for the treatment of various diseases.

Features of the Global Bioanalytical Testing Services Market

Market Size Estimates: Bioanalytical testing services market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bioanalytical testing services market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Bioanalytical testing services market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the bioanalytical testing services market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bioanalytical testing services market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the bioanalytical testing services market size?

Answer: The global bioanalytical testing services market is expected to reach an estimated $9.4 billion by 2030.

Q2. What is the growth forecast for bioanalytical testing services market?

Answer: The global bioanalytical testing services market is expected to grow with a CAGR of 15.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bioanalytical testing services market?

Answer: The major drivers for this market are increasing emphasis towards the development of advanced bioanalytical technologies for enhanced testing and growing trend of outsourcing laboratory testing services.

Q4. What are the major segments for bioanalytical testing services market?

Answer: The future of the bioanalytical testing services market looks promising with opportunities in the oncology, neurology, infectious diseases, gastroenterology, and cardiology markets.

Q5. Who are the key bioanalytical testing services market companies?

Answer: Some of the key bioanalytical testing services companies are as follows:

  • Charles River
  • Medpace
  • WuXi AppTec
  • Eurofins Scientific
  • IQVIA
  • SGS SA
  • Laboratory Corporation
  • Intertek
  • Syneos Health
  • ICON

Q6. Which bioanalytical testing services market segment will be the largest in future?

Answer: Lucintel forecasts that cell-based assays will remain the largest segment over the forecast period due to high occurence of chronic diseases and the increasing number of clinical trials.

Q7. In bioanalytical testing services market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing emphasis on developing new drugs for the treatment of various diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bioanalytical testing services market by type (cell-based assays, bacterial cell-based assays, viral cell-based assays, virology testing, in vitro virology testing, in vivo virology testing, species-specific viral PCR assays, method development, optimization, and validation, and others), application (oncology, neurology, infectious diseases, gastroenterology, and cardiology), end use (pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, and contract research organizations), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bioanalytical Testing Services Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bioanalytical Testing Services Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bioanalytical Testing Services Market by Type
    • 3.3.1: Cell-Based Assays
    • 3.3.2: Bacterial Cell-Based Assays
    • 3.3.3: Viral Cell-Based Assays
    • 3.3.4: Virology Testing
    • 3.3.5: In Vitro Virology Testing
    • 3.3.6: In Vivo Virology Testing
    • 3.3.7: Species-Specific Viral PCR Assays
    • 3.3.8: Method Development, Optimization, and Validation
    • 3.3.9: Others
  • 3.4: Global Bioanalytical Testing Services Market by Application
    • 3.4.1: Oncology
    • 3.4.2: Neurology
    • 3.4.3: Infectious Diseases
    • 3.4.4: Gastroenterology
    • 3.4.5: Cardiology
  • 3.5: Global Bioanalytical Testing Services Market by End Use
    • 3.5.1: Pharmaceutical and Biopharmaceutical Companies
    • 3.5.2: Contract Development and Manufacturing Organizations
    • 3.5.3: Contract Research Organizations

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bioanalytical Testing Services Market by Region
  • 4.2: North American Bioanalytical Testing Services Market
    • 4.2.1: North American Bioanalytical Testing Services Market by Application: Oncology, Neurology, Infectious Diseases, Gastroenterology, and Cardiology
    • 4.2.2: North American Bioanalytical Testing Services Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, and Contract Research Organizations
  • 4.3: European Bioanalytical Testing Services Market
    • 4.3.1: European Bioanalytical Testing Services Market by Application: Oncology, Neurology, Infectious Diseases, Gastroenterology, and Cardiology
    • 4.3.2: European Bioanalytical Testing Services Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, and Contract Research Organizations
  • 4.4: APAC Bioanalytical Testing Services Market
    • 4.4.1: APAC Bioanalytical Testing Services Market by Application: Oncology, Neurology, Infectious Diseases, Gastroenterology, and Cardiology
    • 4.4.2: APAC Bioanalytical Testing Services Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, and Contract Research Organizations
  • 4.5: ROW Bioanalytical Testing Services Market
    • 4.5.1: ROW Bioanalytical Testing Services Market by Application: Oncology, Neurology, Infectious Diseases, Gastroenterology, and Cardiology
    • 4.5.2: ROW Bioanalytical Testing Services Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, and Contract Research Organizations

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bioanalytical Testing Services Market by Type
    • 6.1.2: Growth Opportunities for the Global Bioanalytical Testing Services Market by Application
    • 6.1.3: Growth Opportunities for the Global Bioanalytical Testing Services Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bioanalytical Testing Services Market by Region
  • 6.2: Emerging Trends in the Global Bioanalytical Testing Services Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bioanalytical Testing Services Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bioanalytical Testing Services Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Charles River
  • 7.2: Medpace
  • 7.3: WuXi AppTec
  • 7.4: Eurofins Scientific
  • 7.5: IQVIA
  • 7.6: SGS SA
  • 7.7: Laboratory Corporation
  • 7.8: Intertek
  • 7.9: Syneos Health
  • 7.10: ICON